Roche and PathAI: Defining the next era of digital pathology
Combining state-of-the-art, AI-powered digital pathology technologies with leading diagnostic platforms to transform precision oncology
To lead the next era of computational pathology, Roche is investing in providing more seamless access to digital pathology for labs, researchers, and patients. Roche is uniting its global footprint and market leadership in tissue diagnostics with PathAI, a leader in digital pathology and AI-powered technology for pathology laboratories and the biopharma industry, to redefine how diagnostics generate value for patients across the globe.
The power of PathAI
Founded by a pathologist and experts in advanced artificial intelligence, PathAI delivers technology solutions that accelerate biomarker discovery and streamline laboratory workflows. The PathAI portfolio includes products and services for translational research, clinical and companion diagnostics development, image management systems (IMS) and AI algorithms, and the Precision Pathology Network. To learn more about the PathAI portfolio, visit the homepage.
PathAI has established proven global scale and scientific leadership through industry-defining accomplishments:
- Works with all of the top 20 global biopharma companies to accelerate biomarker discovery, translational research, clinical trial stratification, and drug development pipelines.1
- Partners with laboratories worldwide to digitize and manage over 100 million whole slide images through the AISight® Dx IMS platform.1
- Delivers a comprehensive menu of AI pathology products for workflow optimization and biomarker quantification.*
Roche and PathAI empower modern laboratories with a unified, open digital pathology platform driving operational efficiency, simplifying enterprise integration, and advancing research and precision diagnostics across patient care.
*AISight® and PathAI AI tools are for Research Use Only. Not for use in diagnostic procedures
Digital pathology with Roche and PathAI
In a digital workflow, clinical and research laboratories face complexities of managing multiple vendors, disjointed contracts, and fragmented service teams. To truly operationalize digital pathology, labs need a partner that simplifies how they do business.
With more than 20 years of experience in digital pathology and lab automation, Roche delivers a complete partnership with streamlined:
Interoperability &
enterprise flexibility
Roche and PathAI deliver an open and interoperable digital pathology ecosystem.
AISight supports integration with multiple scanner models, AI algorithms, and bidirectional LIS integration to seamlessly connect your enterprise.*
*AISight® and PathAI AI tools are for Research Use Only. Not for use in diagnostic procedures
Contracting
A simplified contract, billing, and procurement pathway
Implementation
A unified installation planning process with an experienced partner.
Support
A single, dedicated contact for technical support and customer success.
Accelerating the future
PathAI built a vertically integrated technology stack trained on a massive, highly curated proprietary dataset including:
- 42.5+ million annotations
- A network of 500+ pathologists providing expert oversight
- A proprietary dataset of over ~800,000 whole slide images
- A state-of-the-art universal transformer foundation model PLUTO pre-trained on ~2,000,000 image tiles for rapid adaptation to diverse tasks1
Roche and PathAI established a relationship in 2024 to develop AI-enabled digital pathology algorithms in the companion diagnostics space.2 The centerpiece of this ecosystem is AISight® Dx — a robust, open image management system (IMS) that is FDA-cleared for primary diagnosis with VENTANA® slide scanners.
With PLUTO as the backbone behind PathAI’s large menu of AI algorithms, Roche and PathAI are bringing unprecedented precision to the future of clinical diagnostics, companion diagnostics, and biopharma research.
Power your pathology lab with AI.
Complete the form below to learn how Roche Diagnostics and PathAI can streamline and transform your digital workflow.
The road ahead
Bringing together Roche’s footprint in the anatomic pathology lab with PathAI’s innovative IMS and AI tools, Roche is excited to support the laboratory's digital transformation. To learn more about the PathAI portfolio, visit the homepage.
References
- Data on file.
- PathAI, "PathAI Announces Exclusive Collaboration with Roche Tissue Diagnostics to Advance AI-enabled Interpretation for Companion Diagnostics" (February 13, 2024).